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Mesangial cell killing by leukocytes: Role of leukocyte oxidants and
proteolytic enzymes. Mesangial cells from human and rat kidney were
examined for sensitivity to killing by neutrophils. Cells from both
species were sensitive to killing by phorbol myristate acetate-stimulated
neutrophils. Catalase was highly protective while superoxide dismutase
was less protective and a number of protease inhibitors were not
protective. Strong protection was also observed with the iron chelators,
deferoxamine and phenanthroline, and with the hydroxyl radical scav-
engers, dimethylthiourea and 5,5-dimethyl-l-pyrroline N-oxide. Pre-
treatment of the mesangial cells with deferoxamine followed by washing
also provided protection. Mesangial cells were also killed by reagent
hydrogen peroxide (H202) but were much less sensitive to injury by
direct application of proteolytic enzymes. The ability of H202 to injure
mesangial cells was prevented by pre-incubation of the H202 with
human leukocyte myeloperoxidase. These data suggest that killing is
due primarily to the generation of H202 by the stimulated neutrophils
and its further reduction in an iron-catalyzed reaction. The hydroxyl
radical may be the reduction product that actually mediates lethal injury
but lack of scavenger specificity prevents definitively concluding this.
Mesangial cell killing by activated neutrophils could be significantly
inhibited by monoclonal antibodies to CDI I/CD 18 molecules, suggest-
ing that close contact between the target and effector cells is required
for cytotoxicity. Although qualitatively similar to endothelial cells, the
mesangial cells appeared to be quantitatively more oxidant sensitive
than previously examined human and rat endothelial cells. Taken
together, these data show that mesangial cells from rat and human are
sensitive to leukocyte-induced injury and that injury results via an
oxidant pathway. Mesangial cell injury is noted in a variety of glomer-
ulopathies where oxidant-mediated mechanisms may play a role in the
pathogenic process.
Infiltrates of inflammatory cells (neutrophils and monocytes)
are seen in a variety of glomerulopathies. In complement-
dependent models of anti-glomerular basement membrane (anti-
GBM) nephritis in the rat and rabbit (among the most well-
studied models), there is strong evidence that the infiltrating
leukocytes are responsible for the injury F 1—31. Neutrophils can
be seen in the glomerulus within three to four hours of antibody
administration. Proteinuria develops rapidly and correlates with
the number of neutrophils observed in the glomerulus. In
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addition, injury can be prevented by prior neutrophil depletion.
Monocytes are less prominent during this early (heterologous)
phase but become abundant during the later (autologous) phase
[3, 4]. An important role for neutrophil proteolytic enzymes in
the early phase has been shown [1, 5—71, but as in other forms
of acute inflammatory disease, much of the damage can be
attributed to the production of oxygen radicals by the infiltrat-
ing leukocytic cells [2, 4, 8—14].
In the kidney, as in other organs undergoing acute inflamma-
tory injury, the micro-vasculature appears to be the primary
target of injury. Characteristic features include destruction of
glomerular endothelial cells [8] and breakdown of the subendo-
theliat basement membrane [8]. In contrast to the microvascu-
lature of most organs, the microvasculature of the glomerulus
contains smooth muscle-like (mesangial) cells and visceral
epithelial cells in addition to endothelium. Mesangial cells are
somewhat unique. They have the capacity to synthesize large
amounts of extracellular matrix components [15] and are similar
in this respect to smooth muscle cells. Additionally, mesangial
cells have been shown to synthesize readily detectable amounts
of reactive oxygen metabolites such as superoxide anion [16—
19]. Given their location within the glomerulus and their capac-
ity to synthesize oxidants, it would not be unreasonable to find
that mesangial cells are also a target of inflammatory injury.
This is, in fact, the case. Mesangial cells are injured during
acute leukocyte-mediated glomerulonephritis [9, 14, 20, 21] as
well as in a variety of other glomerulopathies [21].
Although mesangial cells are targets of inflammatory injury,
the mechanism(s) through which injury occurs is unclear. The
present study was carried out, therefore, to examine mesangial
cells in vitro for sensitivity to injury by leukocytes and to
elucidate pathways leading to injury. Although mesangial cells
have not been characterized in this manner previously, endo-
thelial cells from a variety of species have been examined in
detail [22—321. We were able to utilize this information in
designing experiments with mesangial cells. The data obtained
in these studies indicate that mesangial cells are killed by
leukocytes in vitro and that killing is, to a large extent,
oxidant-mediated. Further, the present data indicate that killing
is related to the conversion of hydrogen peroxide (H202) to
hydroxyl radical in an iron-catalyzed reaction.
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Methods
Mesangial cells
Human and rat mesangial cells were used in this study. Most
of the experiments conducted with rat cells utilized a cloned
line (referred to as rat mesangial cell isolate 1) which was
isolated and characterized as described previously [33]. In
brief, glomeruli from male Fisher rats were isolated by graded
sieving and differential centrifugation. After subsequent colla-
genase treatment, the glomeruli were washed and plated in
RPMI-1640 medium supplemented with 20% fetal bovine se-
rum, 20 m glucose, 18 ng/ml hydrocortisone, 3 pg/mI triiodo-
thyronine and ITS Premix (Collaborative Research, Boston,
Massachusetts, USA) to provide 5 tg/ml insulin, 5 g/ml
transferrin and 2.63 nglml selenium. Glomerular epithelial cells
were abundant during primary culture but were eventually
overgrown by mesangial cells (approximately 4 weeks). The
latter were then harvested by brief exposure to trypsin/EDTA
and further purified by successive subculture. The cells were
characterized as mesangial cells on the basis of (a) ability to
grow in medium containing d-valine, (b) marked increase in
guanosine 5'-cyclic monophosphate content upon exposure to
• atrial natriuretic factor, (c) formation of "cell hillocks" con-
taining abundant amounts of extracellular matrix material, (d)
fusiform appearance and presence of intracellular fibrils by
transmission electron microscopy and (e) presence of dense
cytoplasmic immunochemical staining for type IV collagen,
fibronectin and laminin. The cells were subsequently cloned
and have been repeatedly passaged. They have retained their
mesangial cell characteristics including typical morphology and
extracellular matrix profiles [331.
Some experiments were conducted with two other popula-
tions of rat mesangial cells (referred to as rat mesangial cell
isolate 2 and isolate 3). These cells were also obtained from
Fisher rats as described above [33]. One of the isolates (isolate
2) was examined at low passage (<10) while the other isolate
was a cloned line. These cells were sensitive to lysis with
anti-Thy I antibody, expressed smooth muscle specific actin,
vimentin and desmin. They were negative for cytokeratin and
acetylated low density lipoprotein receptor.
Human mesangial cells were prepared employing the same
method starting with two different kidneys considered not
suitable for transplantation. The human mesangial cell popula-
tions (referred to as human mesangial cell isolate 1 and isolate
2) were maintained in the same culture medium as the rat
mesangial cells and used at passage 2-4. The human mesangial
cells were characterized with regard to the same characteristics
as the rat cells (that is, morphology, formation of hillocks
containing abundant amounts of extracellular matrix and dense
intracellular staining for extracellular matrix components in-
cluding types I and IV collagen, laminin and fibronectin).
Neutrophils
Human peripheral blood neutrophils were obtained from
healthy adult volunteers by ficoll-hypaque density gradient
separation and dextran sedimentation as described previously
[221. Upon isolation, the cells were suspended in Hanks'
balanced salt solution (HBSS). Examination of Wright-Giemsa
stained cytospin preparations revealed 95 to 98% granulocytes.
Rat glycogen-induced peritoneal leukocytes were also used.
These cells were obtained four hours after intraperitoneal
injection of 1% glycogen and suspended in HBSS. Normally,
the peritoneal exudate cells were greater than 95% granulo-
cytes.
Reagents
Phorbol myristate acetate (PMA), hydrogen peroxide (H202;
30% solution), soybean trypsin inhibitor, lima bean trypsin
inhibitor, aprotinin, 5 ,5-dimethyl- I -pyrroline N-oxide (DMPO),
mannitol, catalase, I , lO-phenanthroline, human leukocyte my-
eloperoxidase, trypsin (bovine pancreas) and elastase (hog
pancreas) were obtained from Sigma Chemical Company (St.
Louis, Missouri, USA). Superoxide dismutase was obtained
from DDI Pharmaceuticals Inc. (Mountain View, California,
USA). Deferoxamine was obtained from Ciba-Geigy (Summit,
New Jersey, USA). Dimethylthiourea (DMTU) was obtained
from Aldrich Chemical Co. (Milwaukee, Wisconsin, USA) and
tissue inhibitor of metalloproteinase-2 (TIMP-2) was a gift from
Amgen (Thousand Oaks, California, USA).
Monoclonal antibodies
Mouse monoclonal antibodies to human CDlla (clone 2F12,
IgGI), human CDllb (clone 17, 1gM), human CD11c (clone
L29, IgGI) and human CD18 (clones TS1/l8, IgGl and 1B4,
IgGl) were used in this study. An irrelevant mouse IgGI and
normal mouse 1gM were used as controls. All were in the form
of ascites fluid except for clone L29, which was used as a
purified IgG. Clone 2F12 was a gift from Dr. Jerome Ritz (Dana
Farber Cancer Center, Boston, Massachusetts, USA) [34],
clone L29 was a gift from Dr. Lewis Lanier (Becton Dickinson
Monoclonal Antibody Center, San Jose, California, USA) [35]
and clone 1B4 was a gift from Dr. Sam Wright (Rockerfeller
University, New York, New York, USA) [36]. Clone 17 was
prepared in our laboratory [37] and clone TS1/18 was obtained
from the American Type Culture Collection [38].
Cytotoxicity assay
A 51Cr-release assay was routinely used to assess mesangial
cell injury. Cells were plated into wells of a 24-well dish (4 X l0
cells/well) in growth medium and treated with I jsCilwell
Na251CrO4. One day later, the cells were washed two times in
HBSS to remove unincorporated 51Cr and were ready to use.
Neutrophils, prepared as described above, were added at 1 to 2
x 106 cells/well (unless otherwise stated) in HBSS containing
200 g/ml bovine serum albumin and activated by the addition
of 50 nM (final concentration) PMA. The amount of 51Cr
released into the supernatant fluid was determined six hours
later when human mesangial cells were used as the target and
1.5 to 2 hours later when rat mesangial cells were used as the
target. The assay has been described in detail with endothelial
cells in the past [22].
In some experiments, reagent H2O2 was used in place of
activated neutrophils as the cytotoxic agent. The cytotoxicity
assay was carried out exactly as with neutrophils. In other
experiments, purified proteolytic enzymes (trypsin or elastase)
were used. Again, the assay was carried out exactly as with
neutrophils. Prior to use, H202 was standardized by the Thur-
man method [39] and proteolytic enzyme activity was standard-
ized based oq ability to solubilize hemoglobin as described
previously [221.
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Table 1. Killing of human and rat mesangial cells by neutrophils
Percent killed
Rat
Condition Isolate:
Human
1 2 1 2 3
Buffer alone
PMA (50 nM)
Human neutrophils
Human neutrophils +
PMA
Rat neutrophils
Rat neutrophils + PMA
11±5 6±1 9±1 3±2 0±18±2 11±4 8±1 8±1 0±15±1 12±4 13±2 9±1 —3±1
77 ia 32 6b 67 r 85 4 81 ia
ND ND 14±2 ND ND
ND ND 20±2 ND ND
Cytotoxicity assays were carried out as described in the Methods
section. Human mesangial cell isolates were examined in a 6-hour
assay. Rat mesangial cell isolates were examined in a 1.5-hour assay.
Values shown represent means and standard deviations based on
triplicate samples/data point in a single experiment. Each population
was examined at least two times with similar results. ND = not done.
Statistical significant levels were determined using the Student t-test as
described in the Methods section.
a Statistical significance, P < 0.0025 b Marginal significance. 0.0025
<P < 0.01
Although we routinely used 51Cr-release as an indicator of
cytotoxicity, we also examined cells under the phase-contrast
microscope after exposure to the injurious stimuli. Whereas
control cells and cells exposed to un-activated neutrophils
retained their cobblestone or spindle-shape morphology and did
not stain with trypan blue, the cells exposed to activated
neutrophils or reagent H202 detached from the plastic surface,
rounded up and became highly granular. Furthermore, one
could see fewer intact cells and a large amount of cell debris in
these cultures. Most of the cells which appeared to be intact
stained with trypan blue. In addition to microscopic examina-
tion and staining with trypan blue, control and injured cells
were harvested with trypsin and replated in growth medium.
Four hours later, the number of cells that had reattached and
spread was determined. The plating efficiency of control cells
examined in this manner was in the range of 85 to 95%. In
contrast, the plating efficiency of cells exposed to injurious
stimuli fell to zero. Cells unable to reattach and spread were
accepted as being lethally injured. This assay has been used
previously to assess cell injury [23, 24].
Statistical significance
Student 1-tests, assuming unequal variance, were used to
compare mean percent killed in the absence of treatment with
the mean percent killed in the presence of neutrophils + PMA
for data in Tables 1 and 3 and in Figures 1 and 2. Student 1-tests,
assuming unequal variances, were used to compare mean
percent killed in the absence of specific inhibitors with mean
percent killed in the presence of the same inhibitors for data in
Tables 2 and 4. Neutrophils + PMA were present throughout.
Means were calculated based on triplicate samples per data
point. Because of the multiplicity of comparisons made, we
used Bonferroni's procedure to ensure an overall, one-sided
type I error of a < 0.05, which resulted in conservative
significance levels. We considered mean percent killed in the
presence of an inhibitor to be significantly less than the mean
percent killed in the absence of the inhibitor if the associated P
value did not exceed 0.0025; differences were considered to be
marginally significant if the associated P value lay within the
range 0.0025 <P < 0.01.
Results
Killing of human and rat mesangial cells by activated
neutrophils
Previous studies have shown that vascular endothelial cells
derived from several species are sensitive to injury by activated
neutrophils. Depending on the cells and the conditions of
treatment, injury may be lethal or non-lethal. Lethal injury may
be oxidant-mediated, protease-mediated or involve a combina-
tion of oxidants and proteases [22—32]. The data in Table 1
indicate that five different mesangial cell populations derived
from either human or rat are also injured by activated neutro-
phils (though not by unstimulated cells). While most of the
studies were carried out using neutrophils isolated from periph-
eral human blood, rat peritoneal exudate cells were also capable
of injuring mesangial cells. Although the degree of injury
induced by rat peritoneal neutrophils was much lower than that
seen with human cells, this may be due to the fact that the
peritoneal neutrophils are already partially activated as a result
of the elicitation process. Rat peritoneal exudate neutrophils
stimulated with PMA produced 2.3 0.3 nmols of 1120, per I
x 10 cells in a 30 minute period whereas human neutrophils
produced 20 1 nmols of H202 under the same conditions.
There are other differences between rat neutrophils and human
neutrophils (such as, in spectrum of proteolytic enzymes) which
could also account for some of the differences between the two
populations in their ability to injure mesangial cells [40].
Dose-response and time-response studies were carried out
with rat mesangial cell isolate I. There was killing with as few
as 5 X j4 effector cells (human neutrophils) per well (approx-
imate effector:target ratio of I : I; Fig. LA). Further, killing
could be seen within 0.5 hours of exposure of the mesangial
cells to the activated neutrophils (Fig. 1B). The low
effector:target ratio and the short period of time needed to
obtain lethal injury suggest that the rat mesangial cells are more
sensitive to injury by activated neutrophils than are rat endo-
thelial cells [24, 31]. Time-response data obtained with the other
two rat mesangial cell isolates are shown for two neutrophil
concentrations in Figure 2. The data with the low-passage rat
cells (isolate 2) and with the other high-passage cells (isolate 3)
indicate that these cells are also quite sensitive to neutrophil-
mediated injury. Injury could be obtained with both populations
by two hours of incubation. It should be noted that the two
human mesangial cell isolates were not examined at the early
time points simply due to lack of cell availability.
A series of potential inhibitors was used in an effort to
elucidate pathways of injury. As seen in Table 2, three different
serine protease inhibitors and a metalloproteinase inhibitor
provided minimal protection against injury to rat mesangial
cells. Likewise, SOD was only modestly protective. In con-
trast, catalase was highly protective against neutrophil-medi-
ated injury of all five mesangial cell populations. Two different
iron chelators (deferoxamine and phenanthroline) were also
highly protective as were two different hydroxyl scavengers
(DMTU and DMPO). In contrast to these effects, very little
protection was observed with mannitol.
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Table 2. Effects of various inhibitors on neutrophil-mediated mesangial cell killing
Treatment Isolate:
Percent killed
Human Rat
I (b) 2 31 2 1 (a)
Human neutrophils 10 2 6 1 8 1 13 2 6 I 7 1
Human neutrophils + PMA 70 II 32 6 68 7 88 3 69 3 61 0
+ SBTI (100 tgIml) ND ND 64 3 86 2 70 1 63 2
+ LBTI (100 g/ml) ND ND 55 2b ND ND ND
+ Aprotinin (100 gImI) ND ND ND 83 2 ND ND
+ TIMP-2 (100 sg/ml) ND ND ND 75 2" ND ND
+ SOD (180 U/mI) ND ND 53 7" ND 48 3W 54 1W
+ Catalase (2000 U/mI) 23 4W 13 4b 31 3W ND 30 3W 26 2W
+ Deferoxamine (1 mM) ND ND 29 4W ND 10 1W 8 1W
+ Phenanthroline (1 mM) ND ND 18 P' ND ND ND
+ DMTU (10 mM) ND ND 49 4b ND 18 a 28 l
+ DMPO (50 mM) ND ND 28 1W ND 8 ia 19 1W
+ Mannitol (55 mM) ND ND 59 2 ND ND ND
Cytotoxicity assays were carried out as described in the Methods section. Human mesangial cell isolates were examined in a 6 hour assay. Rat
mesangial cell isolates were examined in a 1.5 hour assay. Each inhibitor was prepared in buffer and added to the mesangial cells immediately
before addition of neutrophils and PMA. Values shown represent percent killed standard deviations based on triplicate samples per data point
in a single experiment. Each inhibitor was examined 2 to 4 separate times with each mesangial cell isolate. In all experiments, the percent killed
in buffer alone or in buffer + PMA ranged from Ito 14%. Rat mesangial cell isolates Ia and lb refer to separate experiments with the same isolate.
Abbreviations are: SBTI, soybean tripsin inhibitor; LBTI, lima bean tryspin inhibitor; TIMP-2, tissue inhibitor of metalloproteinase-2; SOD,
superoxide dismutase; DMTU, dimethylthiourea; DMPO, 5,5-dimethyl-l-pyrrole N-oxide; and ND, not done. Statistical significance levels were
determined using the Student 1-test as described in the Methods section.
Statistical significance, P < 0.0025
b Marginal significance, 0.0025 <P < 0.01
Table 3. Killing of rat mesangial cells by H202 and H202 +
myeloperoxidase
Treatment Percent killed
None 14±3
10 nmol/ml H202 20 3
50 nmol/ml H202 42 2
100 nmol/ml H202 68
250 nmol/ml H202 71 l
500 nmol/ml H202 69 ia
50 nmol/ml H202
+ 250 mU/mI myeloperoxidase 14 4
Cytotoxicity assays were carried out in the normal manner. When
myeloperoxidase was added to H202, the H202 and myeloperoxidase
were mixed and incubated for 1 hour at room temperature before
exposure of the cells to the resulting solution. Values shown represent
means and standard deviations based on triplicate samples/data point in
a single experiment. The experiment was repeated three times with
similar results. Statistical significance levels were determined using the
Student 1-test as described in the Methods section.
Statistical significance, P < 0.0025
Additional experiments were carried out in which rat mesan-
gial cells (isolate 1) were pretreated for a two-hour period with
deferoxamine (1 to 10 mM) and then washed. Following this,
control mesangial cells and deferoxamine-pretreated cells were
examined for killing by activated neutrophils in the normal
manner. Pre-treatment with deferoxamine followed by washing
reduced subsequent injury by activated neutrophils. In an
experiment in which 60 5% of the control mesangial cells
were killed (against a background of 10 1% injury), 49 8%
and 40 12% of the cells pretreated with 1 mrc or 10 mM
deferoxamine were killed. The ability of deferoxamine to pro-
tect when the target cells werc pretreated and then washed
suggests that the source of iron used in the cytotoxicity process
is the mesangial cells, themselves.
These data indicate that mesangial cell killing by PMA-
activated neutrophils is dependent primarily on the generation
of H202. They are also consistent with the idea that killing is
largely due to the intra (target) cell conversion of H202 to the
hydroxyl radical in an iron-catalyzed reaction. These findings
do not rule out, however, the involvement of other pathways.
In particular, both leukocyte proteolytic enzymes and my-
eloperoxidase products of H202 have been shown to play a role
in glomerular injury in vivo [5—8, 11]. Further, both proteolytic
enzymes [25, 26, 30, 31] and myeloperoxidase products of H202
[41—43] are able to injure a variety of cell types in culture.
Experiments were carried out, therefore, to determine (1) if the
rat mesangial cells were, in fact, sensitive to killing by proteo-
lytic enzymes and (2) if H202 alone would mimic the effects of
activated neutrophils or whether myeloperoxidase was also
required. As indicated in Figure 3, the rat mesangial cells
(isolate 1) were relatively resistant to killing by either bovine
pancreatic trypsin or hog pancreatic elastase. Concentrations as
high as 50 j.g/ml of either enzyme (having equivalent amounts
of hemoglobin hydrolyzing activity as I to 1.5 x 106 freshly-
isolated human neutrophils) produced only minimal 51Cr-re-
lease even after six hours of exposure. Examination of the cells
under phase-contrast microscopy revealed no morphological
alterations in the cells exposed to concentrations of either
enzyme up to approximately 10 ig/ml. At higher concentra-
tions, the cells rounded up and a few detached from the
substratum.
In contrast to the inability of proteolytic enzymes to injure
the mesangial cells, Table 3 shows that exposure of the rat
mesangial cells (isolate 1) to reagent H202 produced injury
within 1.5 hours. Injury was observed at concentrations of
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Fig. 1. Killing of rat mesangia! cells (isolate 1) by PMA -stimulated
neutrophils. (A) Dose-response of neutrophils. Injury was assessed
after 1.5 hours. Values shown represent means and standard deviations
based on three samples per data point in a single experiment. Statistical
significance was achieved at neutrophil numbers greater than I x l0.
(B) Time-response. Neutrophils were used at a concentration of 2 X 106
cells per reaction. Values shown represent means and standard devia-
tions based on three samples per data point in a single experiment.
Statistical significance was achieved at time points of 30 minutes and
beyond. The experiment was repeated two times with similar results.
Fig. 2. Killing of rat mesangial cells (isolate 2 and isolate 3) by
PMA-stimulated neutrophils. Neutrophils were used at concentrations
of 5 X l0 and 1 x 106 cells per reaction. Values shown represent means
and standard deviations based on three samples per data point in a
single experiment. Each cell line was examined three times with similar
results. Symbols are: isolate 2, open symbols; isolate 3, closed symbols;
squares, 5 x l0 neutrophils; circles, I x 106 neutrophils. Statistical
significance was achieved with both concentrations of neutrophils at the
2-hour and 4-hour time points.
Table 4. Role of CDI I/CD 18 molecules in neutrophil-mediated
mesangial cell killing
Antibody__________________ ________________
Human neutrophils
Human neutrophils + PMA
Human neutrophils + PMA +
P181 (IgG)3 BB (1gM)
2F12 (anti-CDlla)
l7aba (anti-CDI lb)
L29 (anti-CD I lc)
TSI/18 (anti-CD18)
1B4 (anti-CD18)
Cytotoxicity assays were carried out as described in the Methods
section. Human mesangial cells (isolate I) were examined in a 6 hour
assay; rat mesangial cells (isolate I) were examined in a 1.5 hour assay.
Antibodies (1:100 final dilution of ascites fluid for each except L29,
which was used at I gIml final concentration) were added to neutro-
phils and incubated for 40 minutes at room temperature. Following this,
cells and antibodies were added to the target cells and PMA (50 nM)
added to activate the neutrophils. Values shown represent mean
percent killed standard deviations based on a single experiment with
3 samples per data point for the human cells and five separate
experiments, each with 3 samples per data point for the rat cells.
Statistical significance levels were determined using the Student I-test
as described in the Methods section.
a Statistical significance, P < 0.0025
b Marginal significance, 0.0025 <P < 0.01
A
70
60
50
40
30
20
10
0
a)
C
a)
C)
a)0
100
80
60
40
20
0
-4
0 5
a)
C
a)0
a)0
V
C
a)2
a)0
Number of neutrophils x 1 0
0
B
1 2 3 4
Time, hours
100
80
60
40
0 1 2
Time, hours
Percent killed
Human Rat
11±2 7±3
62±6 69±8
57 3
52 347 2
32 ia26 l
27 ia
not done
66 6
70 I
35 4a
41 10"24 4
not done
27 ia
H202 as low as 10 to 50 nmol/ml in the 51Cr-release assay. When
the H202-exposed cells were examined under phase-contrast
microscopy after incubation for 1.5 hours, there were clear
morphological indications of severe injury. Many of the cells
had lysed and there was a large amount of cell debris in the
culture fluid. Cells that had not lysed were very granular in
appearance. Virtually 100% of these cells stained positive with
trypan blue. When cells that had not been labeled with 51Cr
were exposed to H202 under the same conditions and then
harvested with trypsin and replated in complete culture me-
dium, they were unable to reattach and spread (not shown).
Thus, in mesangial cells as in endothelial cells, it appears that
release of 51Cr is indicative of lethal injury.
Table 3 also shows the effect of human neutrophil myeloper-
oxidase on H202-mediated killing of rat mesangial cells (isolate
1). Pre-incubation of H202 (SO nmol/ml) with 250 mU of purified
enzyme in chloride-containing buffer (that is, HBSS) for one
hour at room temperature resulted in almost complete detoxi-
fication of the H202, in so far as its ability to injure the
mesangial cells was concerned. Since myeloperoxidase will
convert H202 to hypochlorous acid in the presence of chloride
ion, the finding that we not only did not obtain increased injury
under such conditions but that this treatment actually resulted
0 10 20 30 40 50
in decreased injury relative to what was obtained in the pres-
ence of H202 alone strongly argues against the involvement of
hypochlorous acid as a significant mediator of injury by neutro-
phils.
Role of CDIJ/CDI8 molecules in mesangial cell killing by
neutrophils
Previous studies have shown that CD1 1/CD 18 molecules
mediate adhesive interactions between neutrophils and endo-
thelial cells that result in target cell injury L44, 45] but only
recently have there been studies to identify the molecules
involved in neutrophil-mesangial cell interactions [46]. Mono-
clonal antibodies against CD11a, CD11b, CDIIc and CDI8
were, therefore, examined for ability to interfere with neutro-
phil killing of the mesangial cells. For these experiments,
human peripheral blood neutrophils were prepared as described
above and incubated for 40 minutes at room temperature with
the desired amount of each antibody (1: 100 dilutions of ascites
fluids for CDlla, CD11b and CD18 and 1 pg/mI for CDllc).
Following this, the cells and antibodies were added directly to
the mesangial cell monolayers (human mesangial cell isolate 1
and rat mesangial cell isolate I) and the cytotoxicity assay
carried out in the normal manner. As shown in Table 4,
antibodies against each of the a chains provided partial protec-
tion. When human mesangial cells were used as the target,
anti-CD I Ic was a more effective inhibitor than anti-CD 1 lb.
which in turn was more effective than anti-CD1 Ia. When rat
mesangial cells were used as the target, anti-CD 1 la and anti-
CDI lb provided comparable protection but were less effective
than anti-CD lIc. The protection afforded by anti-CDIIc in both
mesangial cell populations was comparable to protection ob-
tained with anti-CD 18.
Discussion
Mesangial cell injury occurs in a number of glomerulopathies
including immune complex-mediated (complement and leuko-
cyte-dependent) glomerulonephritis, glomerular ischemia, toxic
glomerulopathy, radiation nephritis and transplant rejection [2,
8, 9, 14, 20]. The mechanism of mesangial cell injury, for the
most part, remains unknown. Both leukocyte-derived oxidants
and leukocyte proteases are known to play roles in glomerular
injury in vivo [5—7, 11—13]. Either (or both) could be directly
responsible for injury to mesangial cells. Stratta et al [9] showed
that infusion of xanthine/xanthine oxidase into the kidney
produced injury to mesangial cells. Injury was not abrogated by
concomitant infusion of superoxide dismutase. On the basis of
this information it was suggested that H2O2 was the critical
reagent for mesangial cell injury in vivo. Other studies by
Johnson et al [8, 11] showed that mesangial injury could be
achieved by intra- (renal) arterial injection of myeloperoxidase
followed by H2O2, suggesting that hypochlorous acid or a
metabolite of hypochlorous acid was responsible for injury.
This is consistent with in vitro observations that a number of
different types of cells are sensitive to killing by myeloperox-
idase products of H202 [41—43].
The present study was carried out to define pathways of
mesangial cell injury under in vitro conditions. Our results
showed that five different mesangial cell isolates (2 from human
and 3 from rat) were susceptible to lethal injury by activated
neutrophils and with all five populations, injury was signifi-
cantly inhibited in the presence of catalase. This suggests that
mesangial cell killing by activated neutrophils is an oxidant-
dependent process and that neutrophil H,O7 is a central reac-
tant in the process by which injury is induced. The ability of
reagent H2O2 to duplicate the effects of activated neutrophils
also supports this idea. It is of interest, in this regard, that the
amount of reagent H2O2 needed to produce measureable injury
(approximately 50 M concentration in a 1 ml reaction) is
comparable to the amount of H202 produced by 1 to 2 x 106
stimulated neutrophils in a 30-minute incubation [22]. Addi-
tional studies conducted with the rat mesangial cell isolates
suggested that killing was not due to conversion of H2O2 to
70
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Fig. 3. Resistance of rat mesangial cells (isolate I) to injury by purified
trypsin and elastase. The 51Cr-release cytotoxicity assay was carried
out in the normal manner and cell injury was assessed after 2 hours and
6 hours. Values shows represent means and standard deviations based
on triplicate samples/data point in a single experiment. The experiment
was repeated three times with similar results. Symbols are: 2 hours (•);
6 hours (0).
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myeloperoxidase products. Preincubation of H202 with my-
eloperoxidase did not facilitate cell injury, rather, it greatly
reduced subsequent injury. On the other hand, our data are
consistent with the suggestion that further reduction of the
H202 by intra- (target cell) iron is critical to injury. This is based
on the finding that both deferoxamine and phenanthroline
afforded strong protection against injury. Based on protection
with DMTU and DMPO we can further suggest that the
hydroxyl radical is a likely candidate for the critical reduction
product. It must be remembered, however, that DMTU is also
a scavenger of H202 [47—50] and can also react with hypochlo-
rous acid [50]. Thus, protection with this agent is not definitive
proof of hydroxyl radical involvement. We also did not obtain
good protection against injury with mannitol, another hydroxyl
radical scavenger, although failure of this agent to work may be
explained by its failure to cross cell membranes. Regardless of
the actual radical ultimately involved, it is clear from this data
and from past studies [22, 24, 51, 521 that there are many
similarities between the mesangial cell lines and endothelial
lines in their susceptibility to injury by activated neutrophils.
It should be noted that none of the inhibitors protected the
cells completely. This was in spite of the fact that these reagents
were used in high concentrations and that the same concentra-
tions have been shown in the past to provide almost complete
protection against killing of endothelial cells [22, 24, 5 1—53].
This could indicate that other pathways of injury may also be
involved. In fact, exposure of the mesangial cells to purified
proteolytic enzymes did result in a small amount of cytotoxicity
and treatment of the same cells with protease inhibitors pro-
vided some protection (albeit, minimal) against injury by neu-
trophils. Thus, we do not rule out the possibility that neutrophil
proteases may contribute to injury of mesangial cells in vivo.
Perhaps longer incubation periods would be useful for demon-
strating mesangial cell injury attributable to neutrophil prote-
ases as it has been with endothelial cells [31].
In addition to examining the pathway leading to mesangial
cell injury, we also carried out experiments to identify adhesion
factors responsible for mediating interactions between neutro-
phils and mesangial cells that led to injury. Previous studies
have shown that both neutrophils and monocytes interact with
endothelial cells through members of the /2 integrin family (that
is, CD1 l/CD18 molecules) [35—38, 44, 45] and that blocking
interactions mediated by these molecules prevents injury in
vitro and in vivo [44, 45]. Recently, Denton et al [46] showed
that adhesion of cytokine-activated leukocytes to human
mesangial cells was inhibited with antibodies against CDI lb or
CD18 but not with antibodies to CDI Ia or CD1 lc. In addition,
antibodies to CDI8 partially inhibited mesangial cell injury by
cytokine-activated leukocytes. Our present data also show that
interactions which lead to mesangial cell injury are mediated by
/32 integrins. Antibodies to common /3 subunit (CD 18) provided
the greatest protection (approximately 70%) but antibodies to
each of the three a subunits also protected. An antibody to
CD1 lc provided better protection than antibodies to either
CD1 la or CD! lb. This is of interest because previous studies
have suggested that CD1 lb is most responsible for neutrophil-
endothelial cell interactions [44, 451. Our data may suggest that
CD1 Ic is more important in mediating interactions with mesan-
gial cells. Alternatively, individual antibodies vary in their
ability to block functional activity, and it may be that the one
antibody that we have used to CDI Ic is more effective that the
presently available anti-CD 1 la and anti-CD I lb antibodies. Ad-
ditional antibodies with blocking activity will be required to
fully address this question. Likewise, it will require the avail-
ability of antibodies which react with rat /3, integrins to address
the same question on rat leukocytes. While additional studies
need to be done, we can suggest, based on the data presently
available [46 and present report], that CDI I/CD 18 molecules
participate in neutrophil-mesangial cell interactions that lead to
mesangial cell injury.
Although mesangial cell injury appears to follow the same
general pathway that was previously elucidated with endothe-
hal cells, mesangial cells appear to be quantitatively more
sensitive to oxidant injury than endothelial cells from a variety
of species including rat and human [22, 25—32]. With regard to
cells of rat origin specifically, we found that a much higher
percentage of mesangial cells (with all three isolates) were killed
than rat endothelial cells examined under the same conditions
[22, 31]. Furthermore, a lower concentration of either neutro-
phils or reagent H2O2 was needed to induce measureable injury
of mesangial cells than endothelial cells [241 and, finally,
measureable mesangial cell injury could be seen after shorter
incubation periods [22, 24, 31]. With regard to human cells, the
differential sensitivity may be even greater. Past studies have
shown that human umbilical vein endothelial cells (HUVEC)
are highly resistant to neutrophil-mediated killing unless they
are pretreated with an agent such as BCNU to inhibit the
glutathione peroxidase pathway [53—55]. Recently we showed
that first-passage HUVEC could be lethally injured by activated
neutrophils but that sensitivity to injury fell off rapidly upon
further passage [32]. Human mesangial cells did not show a
similar reduction in sensitivity to injury during in vitro cultiva-
tion.
What accounts for the quantitative differences between en-
dothelial cells and mesangial cells remains to be determined.
We know from past studies with endothelial cells that sensitiv-
ity to injury depends on at least three factors—the ability to
generate intra (endothelial) cell oxidants [24, 51, 53], intracel-
lular levels of anti-oxidants [54—56] and intracellular iron avail-
ability [24, 29, 32, 52, 53]. Each of these factors needs to be
assessed in mesangial cells. While there are no data presently
available in regard to anti-oxidant levels in mesangial cells or
intra (mesangial) cell iron content, it is well-established that
mesangial cells are capable of generating measurable amounts
of oxidants [16—19].
The significance of these in vitro data to mechanisms of
glomerular injury in vivo still needs to be determined. It is
apparent that mesangial cells as well as glomerular endothelial
cells and the glomerular basement membrane are injured in a
variety of glomerulopathies including models of experimental
immune complex-induced glomerulonephritis [21]. In IgG-me-
diated anti-GBM disease, neutrophils are thought to be primar-
ily responsible for the initial injury with monocytes involved in
the later phase [1—4]. Both leukocyte oxidants and proteolytic
enzymes are thought to play roles in the pathophysiology of the
disease process [2, 6, 7, 11—131. The high sensitivity of the
mesangial cells to leukocyte oxidants coupled with their resis-
tance to injury by proteolytic enzymes supports the idea that
oxidant injury to these cells in vivo may be an integral compo-
nent of immune complex-induced golmerulonephritis.
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